Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine and Montelukast in Rheumatoid Arthritis
NCT03770923Phase 3Recruiting
- Start
- Oct 2018
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rupatadine, montelukast in rheumatoid arthritis (RA). Started Oct 2018; status: recruiting.
02
Drugs
rupatadinemontelukast
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03770923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770923.